Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Caitlin E. Cox

December 12, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

Presentation AHA 2023

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Presenter: Jeff Healey

November 16, 2023

News Conference News AHA 2023

Sudden Cardiac Death Declining Among NCAA Athletes

Michael O'Riordan

November 15, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

‘Astonishing’ Rates of CVD Linked to Lead Exposure

Caitlin E. Cox

September 13, 2023

News Daily News

Nonwhite Cardiac Arrest Victims Are More Likely to Die Prehospital: Why?

L.A. McKeown

September 11, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

Caitlin E. Cox

June 26, 2023

News Daily News

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Caitlin E. Cox

June 13, 2023

News Daily News

Air Pollution Can Spur Arrhythmias Soon After Exposure

Caitlin E. Cox

May 01, 2023

News Daily News

More AF Surveillance Needed in Chemotherapy Trials, Meta-analysis Hints

L.A. McKeown

April 06, 2023

News Daily News

Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults

Michael O'Riordan

February 09, 2023

Advertisement

AHA Selects 2023’s Leading Cardiovascular Research

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Sudden Cardiac Death Declining Among NCAA Athletes

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

‘Astonishing’ Rates of CVD Linked to Lead Exposure

Nonwhite Cardiac Arrest Victims Are More Likely to Die Prehospital: Why?

September 2023 News Roundup

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

August 2023 News Roundup

Wintertime Brings Increased IHCA Risk, US Data Show

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Air Pollution Can Spur Arrhythmias Soon After Exposure

More AF Surveillance Needed in Chemotherapy Trials, Meta-analysis Hints

Risk of Sports-Related Sudden Cardiac Arrest Low in Older Adults

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content